158 related articles for article (PubMed ID: 30788193)
1. Palmar-plantar Erythrodysesthesia with Genital Involvement Secondary to Capecitabine Chemoradiotherapy: A Case Report.
Hu HP; Corkum MT; Perera F
Cureus; 2018 Dec; 10(12):e3704. PubMed ID: 30788193
[TBL] [Abstract][Full Text] [Related]
2. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series.
Adames A; O'Brien DR; Kelly AR; Saltz LB; Garcia-Aguilar J; Zinovoy M; Williams V; Wu A; Reyngold M; Hajj C; Crane C; Cercek A; Smith JJ; Markova A; Cuaron J; McCann P; Romesser PB
Int J Colorectal Dis; 2024 May; 39(1):75. PubMed ID: 38780794
[TBL] [Abstract][Full Text] [Related]
3. Scrotal and Penile Erythrodysesthesia Associated with Neoadjuvant Capecitabine Chemoradiation.
Dricken J; Pettke E; Griffin JA; Li HY; Mehta V
Cureus; 2020 Apr; 12(4):e7724. PubMed ID: 32432002
[TBL] [Abstract][Full Text] [Related]
4. Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.
Sapp CM; DeSimone P
Clin Colorectal Cancer; 2007 Jan; 6(5):382-5. PubMed ID: 17311704
[TBL] [Abstract][Full Text] [Related]
5. An exploratory study to identify risk factors for the development of capecitabine-induced Palmar Plantar Erythrodysesthesia (PPE).
Law A; Dyson S; Anthony D
J Adv Nurs; 2015 Aug; 71(8):1825-32. PubMed ID: 25702709
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine-Induced Genital Hand-Foot Syndrome Treated With Topical Tacrolimus.
Chan BL; Wang T
Cureus; 2024 Apr; 16(4):e57570. PubMed ID: 38707169
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-Induced Palmar-Plantar Erythrodysesthesia.
Wahab A; Khakwani M; Ehsan H; Bellam N
Cureus; 2020 Nov; 12(11):e11507. PubMed ID: 33214972
[TBL] [Abstract][Full Text] [Related]
8. Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine.
Ljubojevic Hadzavdic S; Stulhofer Buzina D; Murtezani I; Skerlev M
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e304-e306. PubMed ID: 27987319
[No Abstract] [Full Text] [Related]
9. Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08).
Templeton AJ; Ribi K; Surber C; Sun H; Hsu Schmitz SF; Beyeler M; Dietrich D; Borner M; Winkler A; Müller A; von Rohr L; Winterhalder RC; Rochlitz C; von Moos R; Zaman K; Thürlimann BJ; Ruhstaller T;
Breast; 2014 Jun; 23(3):244-9. PubMed ID: 24656636
[TBL] [Abstract][Full Text] [Related]
10. Anticancer drug induced palmar plantar erythrodysesthesia.
Palaniappan M; Srinivasamurthy S; Dubashi B; Chandrasekaran A
J Clin Diagn Res; 2014 Oct; 8(10):HC01-3. PubMed ID: 25478366
[TBL] [Abstract][Full Text] [Related]
11. Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
Kigen G; Busakhala N; Njiru E; Chite F; Loehrer P
Pan Afr Med J; 2015; 21():228. PubMed ID: 26523170
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-associated palmar-plantar erythrodysesthesia: a case report and review of the literature.
Harris CS; Wang D; Carulli A
J Oncol Pharm Pract; 2014 Feb; 20(1):73-80. PubMed ID: 23478198
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled feasibility trial to evaluate Lawsonia inermis (henna)'s effect on palmar-plantar erythrodysesthesia induced by capecitabine or pegylated liposomal doxorubicin.
Stavrinou M; Tsitsi T; Astras G; Paikousis L; Charalambous A
Eur J Oncol Nurs; 2021 Apr; 51():101908. PubMed ID: 33626423
[TBL] [Abstract][Full Text] [Related]
14. Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment.
Farr KP; Safwat A
Case Rep Oncol; 2011 Apr; 4(1):229-35. PubMed ID: 21537373
[TBL] [Abstract][Full Text] [Related]
15. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.
Kara IO; Sahin B; Erkisi M
Breast; 2006 Jun; 15(3):414-24. PubMed ID: 16188440
[TBL] [Abstract][Full Text] [Related]
16. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
Webster-Gandy JD; How C; Harrold K
Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
[TBL] [Abstract][Full Text] [Related]
17. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Risum S; Langer SW
Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
[TBL] [Abstract][Full Text] [Related]
18. Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy.
Fontenot AL; Furr WJ; Husan A; Khan MW
Cureus; 2021 Nov; 13(11):e20060. PubMed ID: 34993032
[TBL] [Abstract][Full Text] [Related]
19. Liposomal doxorubicin-related palmar-plantar erythrodysesthesia (hand-foot syndrome): a case report.
Ni C; Fang J; Qian H; Xu Q; Shen F
J Int Med Res; 2020 Dec; 48(12):300060520974854. PubMed ID: 33356712
[TBL] [Abstract][Full Text] [Related]
20. A case of palmar hypopigmentation induced by capecitabine in a gastrointestinal cancer patient.
Gratiaux J; Gossery C; Rezzag-Mahcene C; Botsen D; Visseaux L; Slimano F; Bouche O
J Oncol Pharm Pract; 2022 Jan; 28(1):247-249. PubMed ID: 34233543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
